procarbazine has been researched along with Mast-Cell Sarcoma in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Mast-Cell Sarcoma: A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, CC | 1 |
| Ehrke, MJ | 1 |
| Mihich, E | 1 |
1 other study available for procarbazine and Mast-Cell Sarcoma
| Article | Year |
|---|---|
Temporal specificity of procarbazine in the inhibition of mouse immune responses to allogeneic tumor.
Topics: Animals; Female; Immunization; Immunosuppressive Agents; Mast-Cell Sarcoma; Mice; Mice, Inbred C57BL | 1979 |